Literature DB >> 19424842

Design of aging intervention studies: the NIA interventions testing program.

N L Nadon1, R Strong, R A Miller, J Nelson, M Javors, Z D Sharp, J M Peralba, D E Harrison.   

Abstract

The field of biogerontology has made great strides towards understanding the biological processes underlying aging, and the time is ripe to look towards applying this knowledge to the pursuit of aging interventions. Identification of safe, inexpensive, and non-invasive interventions that slow the aging process and promote healthy aging could have a significant impact on quality of life and health care expenditures for the aged. While there is a plethora of supplements and interventions on the market that purport to slow aging, the evidence to validate such claims is generally lacking. Here we describe the development of an aging interventions testing program funded by the National Institute on Aging (NIA) to test candidate interventions in a model system. The development of this program highlights the challenges of long-term intervention studies and provides approaches to cope with the stringent requirements of a multi-site testing program.

Year:  2008        PMID: 19424842      PMCID: PMC2585647          DOI: 10.1007/s11357-008-9048-1

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  79 in total

1.  Optimizing detection of QTLs retarding aging: choice of statistical model and animal requirements.

Authors:  S Klebanov; D E Harrison
Journal:  Mech Ageing Dev       Date:  2002-01       Impact factor: 5.432

2.  Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.

Authors:  Markus Guba; Philipp von Breitenbuch; Markus Steinbauer; Gudrun Koehl; Stefanie Flegel; Matthias Hornung; Christiane J Bruns; Carl Zuelke; Stefan Farkas; Matthias Anthuber; Karl-Walter Jauch; Edward K Geissler
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

3.  Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats.

Authors:  Atsushi Kuno; Tamaki Yamada; Kazuhiko Masuda; Kumiko Ogawa; Mitsue Sogawa; Soichi Nakamura; Takahiro Nakazawa; Hirotaka Ohara; Tomoyuki Nomura; Takashi Joh; Tomoyuki Shirai; Makoto Itoh
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

4.  Housing density does not influence the longevity effect of calorie restriction.

Authors:  Yuji Ikeno; Gene B Hubbard; Shuko Lee; Arlan Richardson; Randy Strong; Vivian Diaz; James F Nelson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-12       Impact factor: 6.053

5.  Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology.

Authors:  Thomas van Groen; Inga Kadish
Journal:  Brain Res Brain Res Rev       Date:  2005-04

6.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Authors:  Konrad T Howitz; Kevin J Bitterman; Haim Y Cohen; Dudley W Lamming; Siva Lavu; Jason G Wood; Robert E Zipkin; Phuong Chung; Anne Kisielewski; Li-Li Zhang; Brandy Scherer; David A Sinclair
Journal:  Nature       Date:  2003-08-24       Impact factor: 49.962

7.  Body weight, hormones and T cell subsets as predictors of life span in genetically heterogeneous mice.

Authors:  James M Harper; Andrzej T Galecki; David T Burke; Richard A Miller
Journal:  Mech Ageing Dev       Date:  2004-05       Impact factor: 5.432

8.  Marker loci associated with life span in genetically heterogeneous mice.

Authors:  R A Miller; C Chrisp; A U Jackson; D Burke
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1998-07       Impact factor: 6.053

9.  Dietary fat- and phenobarbital-induced alterations in hepatic antioxidant functions of mice.

Authors:  M Ahotupa; J C Bereziat; E Mäntylä; H Bartsch
Journal:  Carcinogenesis       Date:  1993-06       Impact factor: 4.944

10.  Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy.

Authors:  Silvia Brunelli; Clara Sciorati; Giuseppe D'Antona; Anna Innocenzi; Diego Covarello; Beatriz G Galvez; Cristiana Perrotta; Angela Monopoli; Francesca Sanvito; Roberto Bottinelli; Ennio Ongini; Giulio Cossu; Emilio Clementi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-20       Impact factor: 11.205

View more
  64 in total

Review 1.  Calorie restriction: what recent results suggest for the future of ageing research.

Authors:  Daniel L Smith; Tim R Nagy; David B Allison
Journal:  Eur J Clin Invest       Date:  2010-05       Impact factor: 4.686

2.  The Geropathology Research Network: An Interdisciplinary Approach for Integrating Pathology Into Research on Aging.

Authors:  Warren Ladiges; Yuji Ikeno; Laura Niedernhofer; Richard A McIndoe; Marcia A Ciol; Jerry Ritchey; Denny Liggitt
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-08-04       Impact factor: 6.053

3.  Depressed pacemaker activity of sinoatrial node myocytes contributes to the age-dependent decline in maximum heart rate.

Authors:  Eric D Larson; Joshua R St Clair; Whitney A Sumner; Roger A Bannister; Cathy Proenza
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-15       Impact factor: 11.205

Review 4.  Aging biology and novel targets for drug discovery.

Authors:  David G Le Couteur; Andrew J McLachlan; Ronald J Quinn; Stephen J Simpson; Rafael de Cabo
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-06-21       Impact factor: 6.053

Review 5.  Autophagy and cartilage homeostasis mechanisms in joint health, aging and OA.

Authors:  Martin K Lotz; Beatriz Caramés
Journal:  Nat Rev Rheumatol       Date:  2011-08-02       Impact factor: 20.543

Review 6.  Aging and cancer: can mTOR inhibitors kill two birds with one drug?

Authors:  Zelton Dave Sharp; Arlan Richardson
Journal:  Target Oncol       Date:  2011-03-11       Impact factor: 4.493

Review 7.  Rapamycin and ageing: when, for how long, and how much?

Authors:  Matt Kaeberlein
Journal:  J Genet Genomics       Date:  2014-08-07       Impact factor: 4.275

Review 8.  Taming expectations of metformin as a treatment to extend healthspan.

Authors:  Adam R Konopka; Benjamin F Miller
Journal:  Geroscience       Date:  2019-02-12       Impact factor: 7.713

Review 9.  Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity.

Authors:  Douglas R Seals; Jamie N Justice; Thomas J LaRocca
Journal:  J Physiol       Date:  2015-03-11       Impact factor: 5.182

10.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.

Authors:  David E Harrison; Randy Strong; Zelton Dave Sharp; James F Nelson; Clinton M Astle; Kevin Flurkey; Nancy L Nadon; J Erby Wilkinson; Krystyna Frenkel; Christy S Carter; Marco Pahor; Martin A Javors; Elizabeth Fernandez; Richard A Miller
Journal:  Nature       Date:  2009-07-08       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.